In the last 12 months, insiders at Evommune, Inc. ($EVMN) filed 76 transactions with the SEC: 5 open-market purchases totaling $70,017,350 and 0 sales totaling $0. Net insider sentiment: net buying.
Evommune, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- LSP 7 Cooperative UA (Not found) — 6 transactions totaling $34,999,998
- Verduyn-van Weegen Felice Isabel (Not found) — 6 transactions totaling $34,999,998
- RA CAPITAL MANAGEMENT, L.P. (Not found) — 7 transactions totaling $21,000,000
- Pena Luis C. (President & CEO) — 4 transactions totaling $501,982
- Moss Gregory S. (Chief Business & Legal Officer) — 4 transactions totaling $243,052
View all SEC Filings for Evommune, Inc. (EVMN).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | LSP 7 Cooperative UA | Not found | A | Common Stock | 358680 | $27.88 | 5,288,313.0000 | 31,524,093 | 7.28% | 1.14% |
| Feb. 17, 2026 | Verduyn-van Weegen Felice Isabel | Not found | A | Common Stock | 358680 | $27.88 | 5,288,313.0000 | 31,524,093 | 7.28% | 1.14% |
| Feb. 17, 2026 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Common Stock | 35868 | $27.88 | 3,494,638.0000 | 31,524,093 | 1.04% | 0.11% |
| Dec. 19, 2025 | Hopfner Robert Lorne | Director | P | Common Stock | 1000 | $17.35 | 3,372,001.0000 | 31,524,093 | 0.03% | 0.00% |
| Dec. 8, 2025 | Bauer Eugene | Chief Medical Officer | A | Employee Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 9, 2025 | Pena Luis C. | President & CEO | F | Common Stock | 28138 | $17.84 | 654,683.0000 | 0 | 4.12% | 0.00% |
| Dec. 9, 2025 | Bauer Eugene | Chief Medical Officer | F | Common Stock | 1478 | $17.84 | 270,818.0000 | 0 | 0.54% | 0.00% |
| Dec. 9, 2025 | Carver Kyle | Chief Financial Officer | F | Common Stock | 13290 | $17.84 | 62,510.0000 | 0 | 17.53% | 0.00% |
| Dec. 9, 2025 | Patel Jeegar Pravinkumar | Chief Scientific Officer | F | Common Stock | 7513 | $17.84 | 49,578.0000 | 0 | 13.16% | 0.00% |
| Dec. 9, 2025 | Moss Gregory S. | Chief Business & Legal Officer | F | Common Stock | 13624 | $17.84 | 64,010.0000 | 0 | 17.55% | 0.00% |
| Dec. 9, 2025 | Drew Janice Suzann | EVP, Operations | F | Common Stock | 5074 | $17.84 | 67,794.0000 | 0 | 6.96% | 0.00% |
| Nov. 7, 2025 | Pivotal bioVenture Partners Fund I, L.P. | Director | C | Series C Preferred Stock | 2508575 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 1517329 | $0.00 | 1,517,329.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Common Stock | 691441 | $0.00 | 691,441.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 1157096 | $16.00 | 2,674,425.0000 | 0 | 76.26% | 0.00% |
| Nov. 7, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 92904 | $16.00 | 784,345.0000 | 0 | 13.44% | 0.00% |
| Nov. 7, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series C Preferred Stock | 12924620 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | C | Series C Preferred Stock | 5889699 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | LSP 7 Cooperative UA | Not found | C | Common Stock | 3367133 | $0.00 | 3,367,133.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2025 | LSP 7 Cooperative UA | Not found | P | Common Stock | 1562500 | $16.00 | 4,929,633.0000 | 0 | 46.40% | 0.00% |
| Nov. 7, 2025 | LSP 7 Cooperative UA | Not found | C | Series A Preferred Stock | 15493466 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | LSP 7 Cooperative UA | Not found | C | Series B Preferred Stock | 5090000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | LSP 7 Cooperative UA | Not found | C | Series C Preferred Stock | 6585011 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Verduyn-van Weegen Felice Isabel | Not found | C | Common Stock | 3367133 | $0.00 | 3,367,133.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2025 | Verduyn-van Weegen Felice Isabel | Not found | P | Common Stock | 1562500 | $16.00 | 4,929,633.0000 | 0 | 46.40% | 0.00% |
| Nov. 7, 2025 | Verduyn-van Weegen Felice Isabel | Not found | C | Series A Preferred Stock | 15493466 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Verduyn-van Weegen Felice Isabel | Not found | C | Series B Preferred Stock | 5090000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Verduyn-van Weegen Felice Isabel | Not found | C | Series C Preferred Stock | 6585011 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Pena Luis C. | President & CEO | C | Common Stock | 24225 | $0.00 | 682,821.0000 | 0 | 3.68% | 0.00% |
| Nov. 7, 2025 | Pena Luis C. | President & CEO | C | Series Seed Preferred Stock | 206355 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Patel Jeegar Pravinkumar | Chief Scientific Officer | C | Common Stock | 3175 | $0.00 | 57,091.0000 | 0 | 5.89% | 0.00% |
| Nov. 7, 2025 | Patel Jeegar Pravinkumar | Chief Scientific Officer | C | Series B Preferred Stock | 25000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Moss Gregory S. | Chief Business & Legal Officer | C | Common Stock | 3175 | $0.00 | 77,634.0000 | 0 | 4.26% | 0.00% |
| Nov. 7, 2025 | Moss Gregory S. | Chief Business & Legal Officer | C | Series B Preferred Stock | 25000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Hopfner Robert Lorne | Not found | C | Common Stock | 3026 | $0.00 | 3,371,001.0000 | 0 | 0.09% | 0.00% |
| Nov. 7, 2025 | Hopfner Robert Lorne | Not found | C | Common Stock | 1441032 | $0.00 | 3,371,001.0000 | 0 | 74.67% | 0.00% |
| Nov. 7, 2025 | Hopfner Robert Lorne | Not found | C | Common Stock | 1632441 | $0.00 | 3,371,001.0000 | 0 | 93.90% | 0.00% |
| Nov. 7, 2025 | Hopfner Robert Lorne | Not found | C | Common Stock | 294502 | $0.00 | 3,371,001.0000 | 0 | 9.57% | 0.00% |
| Nov. 7, 2025 | Hopfner Robert Lorne | Not found | C | Series Seed Preferred Stock | 25790 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Hopfner Robert Lorne | Not found | C | Series Seed Preferred Stock | 7145647 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Hopfner Robert Lorne | Not found | C | Series Seed Preferred Stock | 3572816 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Hopfner Robert Lorne | Not found | C | Series A Preferred Stock | 2582243 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Hopfner Robert Lorne | Not found | C | Series A Preferred Stock | 7230283 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Hopfner Robert Lorne | Not found | C | Series B Preferred Stock | 1895260 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Hopfner Robert Lorne | Not found | C | Series B Preferred Stock | 2104740 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Hopfner Robert Lorne | Not found | C | Series C Preferred Stock | 313571 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Hopfner Robert Lorne | Not found | C | Series C Preferred Stock | 313571 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Pivotal bioVenture Partners Fund I, L.P. | Director | C | Common Stock | 1441032 | $0.00 | 1,441,032.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2025 | Drew Janice Suzann | EVP, Operations | C | Common Stock | 1587 | $0.00 | 72,868.0000 | 0 | 2.23% | 0.00% |
| Nov. 7, 2025 | Drew Janice Suzann | EVP, Operations | C | Series B Preferred Stock | 12500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Cohen David E | Not found | C | Common Stock | 6056 | $0.00 | 23,665.0000 | 0 | 34.39% | 0.00% |
| Nov. 7, 2025 | Cohen David E | Not found | C | Series Seed Preferred Stock | 51588 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Carver Kyle | Chief Financial Officer | C | Common Stock | 3175 | $0.00 | 75,800.0000 | 0 | 4.37% | 0.00% |
| Nov. 7, 2025 | Carver Kyle | Chief Financial Officer | C | Series B Preferred Stock | 25000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Bauer Eugene | Chief Medical Officer | C | Common Stock | 25812 | $0.00 | 272,296.0000 | 0 | 10.47% | 0.00% |
| Nov. 7, 2025 | Bauer Eugene | Chief Medical Officer | C | Series Seed Preferred Stock | 206355 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Bauer Eugene | Chief Medical Officer | C | Series B Preferred Stock | 12500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Hopfner Robert Lorne | Not found | C | Series C Preferred Stock | 2508575 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Pivotal bioVenture Partners Fund I, L.P. | Director | C | Common Stock | 1632441 | $0.00 | 1,632,441.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2025 | Pivotal bioVenture Partners Fund I, L.P. | Director | C | Common Stock | 294502 | $0.00 | 294,502.0000 | 0 | 9999.99% | 0.00% |
| Nov. 7, 2025 | Pivotal bioVenture Partners Fund I, L.P. | Director | C | Series Seed Preferred Stock | 7145647 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Pivotal bioVenture Partners Fund I, L.P. | Director | C | Series Seed Preferred Stock | 3572816 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Pivotal bioVenture Partners Fund I, L.P. | Director | C | Series A Preferred Stock | 2582243 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Pivotal bioVenture Partners Fund I, L.P. | Director | C | Series A Preferred Stock | 7230283 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Pivotal bioVenture Partners Fund I, L.P. | Director | C | Series B Preferred Stock | 1895260 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Pivotal bioVenture Partners Fund I, L.P. | Director | C | Series B Preferred Stock | 2104740 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Pivotal bioVenture Partners Fund I, L.P. | Director | C | Series C Preferred Stock | 313571 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 7, 2025 | Pivotal bioVenture Partners Fund I, L.P. | Director | C | Series C Preferred Stock | 313571 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 5, 2025 | Moss Gregory S. | Chief Business & Legal Officer | A | Employee Stock Option (Right to Buy) | 293496 | $0.00 | 293,496.0000 | 0 | 9999.99% | 0.00% |
| Nov. 5, 2025 | Pena Luis C. | President & CEO | A | Employee Stock Option (Right to Buy) | 796841 | $0.00 | 796,841.0000 | 0 | 9999.99% | 0.00% |
| Nov. 5, 2025 | Carver Kyle | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 279408 | $0.00 | 279,408.0000 | 0 | 9999.99% | 0.00% |
| Nov. 5, 2025 | Drew Janice Suzann | EVP, Operations | A | Employee Stock Option (Right to Buy) | 231274 | $0.00 | 231,274.0000 | 0 | 9999.99% | 0.00% |
| Nov. 5, 2025 | Patel Jeegar Pravinkumar | Chief Scientific Officer | A | Employee Stock Option (Right to Buy) | 179619 | $0.00 | 179,619.0000 | 0 | 9999.99% | 0.00% |
| Nov. 5, 2025 | MCGRAW BENJAMIN F III | Not found | A | Stock Option (Right to Buy) | 37960 | $0.00 | 37,960.0000 | 0 | 9999.99% | 0.00% |
| Nov. 5, 2025 | KIRSCH ARTHUR S | Not found | A | Stock Option (Right to Buy) | 37960 | $0.00 | 37,960.0000 | 0 | 9999.99% | 0.00% |
| Nov. 5, 2025 | Cohen David E | Not found | A | Stock Option (Right to Buy) | 37960 | $0.00 | 37,960.0000 | 0 | 9999.99% | 0.00% |